Switch to Standard View
MyBreastCancerTreatment.org

Helping Guide Your Early-Stage Breast Cancer Treatment Decisions.

Printer-Friendly Version

For questions regarding the Oncotype DX® Breast Cancer Assay, please contact Genomic Health Customer Service:

Tel: (866) ONCOTYPE (866-662-6897)
Fax: (650) 556-1073

For questions about breast cancer recurrence, please contact your healthcare provider.

For questions about this site, please contact us at .

 

Register for Updates Send this Web site to a friend
Know someone who's just been diagnosed with breast cancer?

Send to a Friend


Is the Oncotype DX® test right for you?

Find out if you could benefit from the Oncotype DX test by completing our simple candidate profile.

Take Quiz

The information presented on this site is intended to provide patients with newly diagnosed invasive breast cancer, as well as their friends and family, an opportunity to hear how others have incorporated the information provided by the Oncotype DX® Recurrence Score® in making treatment decisions with their doctors. The personal stories featured on this site selected by Genomic Health, Inc., which offers the Oncotype DX® test, are not intended to be representative of patients with breast cancer generally, and should not be considered medical advice. Patients should consult their doctor to determine the best treatment decision for their individual disease.

American Society of Clinical Oncology (ASCO) and ASCO are registered trademarks of ASCO; National Comprehensive Cancer Network (NCCN) and NCCN are registered trademarks of NCCN. ASCO and NCCN do not endorse any product or therapy.

Copyright © 2004-2012 Genomic Health, Inc. All rights reserved. Genomic Health, Oncotype, Oncotype DX, Recurrence Score, and Pass It On: Until Every Woman Knows are trademarks of Genomic Health Inc. MyBreastCancerTreatment.org is sponsored by Genomic Health, Inc., a clinical laboratory in Redwood City, California that developed and offers the Oncotype DX® Breast Cancer Assay. Genomic Health is responsible for the content of MyBreastCancerTreatment.org.